Avior Wealth Management LLC Sells 11,099 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Avior Wealth Management LLC reduced its holdings in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 43.6% in the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 14,367 shares of the company's stock after selling 11,099 shares during the quarter. Avior Wealth Management LLC's holdings in Option Care Health were worth $502,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Blue Trust Inc. increased its holdings in Option Care Health by 95.4% in the first quarter. Blue Trust Inc. now owns 5,282 shares of the company's stock valued at $185,000 after purchasing an additional 2,579 shares during the period. Janney Capital Management LLC acquired a new stake in Option Care Health during the 1st quarter valued at approximately $369,000. Johnson Investment Counsel Inc. increased its position in Option Care Health by 3.7% during the 1st quarter. Johnson Investment Counsel Inc. now owns 87,691 shares of the company's stock valued at $3,065,000 after purchasing an additional 3,120 shares during the period. State of Alaska Department of Revenue increased its position in Option Care Health by 2.7% during the 1st quarter. State of Alaska Department of Revenue now owns 19,931 shares of the company's stock valued at $696,000 after purchasing an additional 525 shares during the period. Finally, Wealth Enhancement Advisory Services LLC increased its position in Option Care Health by 25.7% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 8,274 shares of the company's stock valued at $289,000 after purchasing an additional 1,691 shares during the period. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on the stock. JPMorgan Chase & Co. increased their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research report on Thursday, March 6th. JMP Securities reiterated a "market outperform" rating and set a $36.00 price target on shares of Option Care Health in a report on Wednesday. Barrington Research reiterated an "outperform" rating and set a $38.00 price target on shares of Option Care Health in a report on Wednesday, April 30th. Finally, UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and raised their target price for the stock from $38.00 to $40.00 in a research note on Wednesday, April 30th. One research analyst has rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $35.50.

Option Care Health Price Performance

Shares of OPCH stock traded down $0.03 during trading hours on Friday, reaching $31.53. The stock had a trading volume of 3,139,850 shares, compared to its average volume of 1,880,046. The stock's fifty day simple moving average is $32.08 and its 200 day simple moving average is $30.63. The company has a current ratio of 1.54, a quick ratio of 1.02 and a debt-to-equity ratio of 0.82. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53. The firm has a market capitalization of $5.16 billion, a PE ratio of 25.43, a PEG ratio of 1.90 and a beta of 0.74.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.36 by $0.04. The firm had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.26 billion. Option Care Health had a net margin of 4.12% and a return on equity of 16.90%. The business's quarterly revenue was up 16.3% compared to the same quarter last year. During the same period last year, the firm earned $0.26 EPS. On average, equities research analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current year.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.